CD123 is a canonical AML biomarker (Testa et al., 2014), whose function is crucial for mediating interleukin-3 (IL-3) signaling across various cell types (Dougan et al., 2019; Yi et al., 2022). The gene discussed is IL3; the disease is acute myeloid leukemia.